DARPA Biostasis

The Biological Technologies Office at DARPA seeks novel approaches to reversibly pause and/or slow the functions and preserve viability of living cells without reliance on cold temperature. This new technology aims to directly address needs within the Dept. of Defense to maintain and deliver biological therapeutics and extend the window of time for effective use of field forward therapeutics.
Funding Opportunity number HR001118S0034 
Grants.gov   https://www.grants.gov/web/grants/view-opportunity.html?oppId=301739